Literature DB >> 28369643

Epicardial clip occlusion of the left atrial appendage during cardiac surgery provides optimal surgical results and long-term stability.

Vojtech Kurfirst1, Aleš Mokrácek1, Júlia Canádyová1, Radim Frána1, Petr Zeman1.   

Abstract

OBJECTIVES: Occlusion of the left atrial appendage (LAA) has become an integral and important part of the surgical treatment of atrial fibrillation. Different methods of surgical occlusion of the LAA have been associated with varying levels of short- and long-term success for closure. The purpose of this study was to evaluate long-term results of epicardial placement and endocardial occlusion in patients undergoing cardiac operative procedures.
METHODS: A total of 101 patients (average age 65.7 years) undergoing cardiac operative procedures with the epicardial AtriClip Exclusion System of the LAA were enrolled in the study. The AtriClip was placed via a sternotomy or a thoracotomy or from a thoracoscopic approach. Postoperative variables, such as thromboembolic events, clip stability and endocardial leakage around the device, were examined by transoesophageal echocardiography (TEE) and/or computed tomography.
RESULTS: Perioperative clip implantation was achieved in 98% of patients. TEE and/or computed tomography conducted during the follow-up period, comprising 1873 patient-months with a mean duration of 18 ± 11 months, revealed no clip migration, no leakage around the device and no clot formation near the remnant cul-de-sac. During the follow-up period, 4 of the cardiac patients experienced transitory ischaemic attacks, whereas no patient experienced a cerebrovascular attack.
CONCLUSIONS: The Epicardial AtriClip Exclusion System of the LAA appears to be a feasable and safe operative method with a high success rate. Long-term follow-up confirmed clip stability, complete occlussion of the LAA and absence of any atrial fibrilation-related thromboembolic events. These results need to be confirmed by a larger, multicentre study.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  AtriClip; Atrial fibrillation; Left atrial appendage closure

Mesh:

Year:  2017        PMID: 28369643     DOI: 10.1093/icvts/ivx065

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  6 in total

1.  Surgical device-enabled epicardial LAA closure to achieve safe, complete, and durable LAA occlusion.

Authors:  Etem Caliskan; James L Cox; Volkmar Falk; Sacha P Salzberg; Maximilian Y Emmert
Journal:  Nat Rev Cardiol       Date:  2018-02-13       Impact factor: 32.419

2.  Left Atrial Appendage Management with the Watchman Device during Hybrid Ablation of Atrial Fibrillation.

Authors:  Mindy Vroomen; Bart Maesen; Justin G Luermans; Harry J Crijns; Jos G Maessen; Mark La Meir; Laurent Pison
Journal:  J Interv Cardiol       Date:  2019-06-26       Impact factor: 2.279

3.  Left atrial appendage elimination techniques: stapled excision versus internal suture obliteration.

Authors:  Yoonjin Kang; Ho Young Hwang; Seohee Joo; Ji Hyeon Park; Ji Seong Kim; Suk Ho Sohn; Jae Woong Choi
Journal:  J Thorac Dis       Date:  2021-11       Impact factor: 2.895

4.  Robotics-assisted epicardial left atrial appendage clip exclusion.

Authors:  Tamim Antaki; Joshua Michaelman; John McGroarty
Journal:  JTCVS Tech       Date:  2021-07-21

5.  Standalone epicardial left atrial appendage exclusion for thromboembolism prevention in atrial fibrillation.

Authors:  Richard Cartledge; Grzegorz Suwalski; Anna Witkowska; Gary Gottlieb; Anthony Cioci; Gilbert Chidiac; Burak Ilsin; Barry Merrill; Piotr Suwalski
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-03-31

6.  Early and Middle-Term Results and Anticoagulation Strategy after Left Atrial Appendage Exclusion Using an Epicardial Clip Device.

Authors:  Akihiro Yoshimoto; Yoshihiro Suematsu; Kanan Kurahashi; Hiroyuki Kaneko; Daisuke Arima; Satoshi Nishi
Journal:  Ann Thorac Cardiovasc Surg       Date:  2020-11-19       Impact factor: 1.520

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.